Hannah Vanrusselt
Leuven, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The Discovery and Preclinical Profile of ALG-000184, a Prodrug of the Potent Hepatitis B Virus Capsid Assembly Modulator ALG-001075.
Journal: Journal of medicinal chemistry
Published: November 22, 2024
An in vivo duck hepatitis B virus model recapitulates key aspects of nucleic acid polymer treatment outcomes in chronic hepatitis B patients.
Journal: Antiviral research
Published: December 11, 2023
CAM-A-dependent HBV core aggregation induces apoptosis through ANXA1.
Journal: JHEP reports : innovation in hepatology
Published: November 10, 2023
Novel non-HAP class A HBV capsid assembly modulators have distinct in vitro and in vivo profiles.
Journal: Journal of virology
Published: September 27, 2023
Class A capsid assembly modulator RG7907 clears HBV-infected hepatocytes through core-dependent hepatocyte death and proliferation.
Journal: Hepatology (Baltimore, Md.)
Published: November 18, 2022
CSF1R inhibition rescues tau pathology and neurodegeneration in an A/T/N model with combined AD pathologies, while preserving plaque associated microglia.
Journal: Acta neuropathologica communications
Published: May 18, 2021
Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo.
Journal: Acta neuropathologica
Published: September 17, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026